Year To Quarter End Consolidated Statement Of Comprehensive Income

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7312808

Concept 2024-01-01 to
2024-06-30
2023-01-01 to
2023-06-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
1,436,000,000 JPY
7,866,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
912,000,000 JPY
3,523,000,000 JPY
Foreign currency translation adjustment
6,680,000,000 JPY
3,042,000,000 JPY
Remeasurements of defined benefit plans, net of tax
49,000,000 JPY
117,000,000 JPY
Other comprehensive income
7,642,000,000 JPY
6,682,000,000 JPY
Comprehensive income
9,078,000,000 JPY
14,549,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
9,078,000,000 JPY
14,547,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
1,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.